Tadalafil is a drug from the phosphodiesterase-5 inhibitors (PDE-5) group, which is used to treat erectile dysfunction (ED), lower urinary tract symptoms (LUTS) caused by benign prostatic hyperplasia (BPH) and ED with LUTS in patients with BPH. The efficacy and safety of tadalafil were reviewed. The focus was on cardiovascular safety of tadalafil due to frequent cardiovascular comorbidities in patients with ED. We concluded that tadalafil is well tolerated and safe in patients with cardiovascular comorbidities and, in addition, has a beneficial effect on the cardiovascular system.
Download full-text PDF |
Source |
|---|
Publication Analysis
Top Keywords
patients cardiovascular
8
safety tadalafil
8
cardiovascular comorbidities
8
cardiovascular
5
[safety tadalafil
4
patients
4
tadalafil patients
4
cardiovascular comorbidities]
4
tadalafil
4
comorbidities] tadalafil
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!